Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Jun 6;2016(6):CD005576.
doi: 10.1002/14651858.CD005576.pub3.

Hypertonic salt solution for peri-operative fluid management

Affiliations
Meta-Analysis

Hypertonic salt solution for peri-operative fluid management

Brad Shrum et al. Cochrane Database Syst Rev. .

Abstract

Background: Fluid excess may place people undergoing surgery at risk for various complications. Hypertonic salt solution (HS) maintains intravascular volume with less intravenous fluid than isotonic salt (IS) solutions, but may increase serum sodium. This review was published in 2010 and updated in 2016.

Objectives: To determine the benefits and harms of HS versus IS solutions administered for fluid resuscitation to people undergoing surgery.

Search methods: In this updated review we have searched the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 4, 2016); MEDLINE (January 1966 to April 2016); EMBASE (January 1980 to April 2016); LILACS (January 1982 to April 2016) and CINAHL (January 1982 to April 2016) without language restrictions. We conducted the original search on April 30th, 2007, and reran it on April 8th, 2016.

Selection criteria: We have included randomized clinical trials (RCTs) comparing HS to IS in people undergoing surgery, irrespective of blinding, language, and publication status.

Data collection and analysis: Two independent review authors read studies that met our selection criteria. We collected study information and data using a data collection sheet with predefined parameters. We have assessed the impact of HS administration on mortality, organ failure, fluid balance, serum sodium, serum osmolarity, diuresis and physiologic measures of cardiovascular function. We have pooled the data using the mean difference (MD) for continuous outcomes. We evaluated heterogeneity between studies by I² percentage. We consider studies with an I² of 0% to 30% to have no or little heterogeneity, 30% to 60% as having moderate heterogeneity, and more than 60% as having high heterogeneity. In studies with low heterogeneity we have used a fixed-effect model, and a random-effects model for studies with moderate to high heterogeneity.

Main results: We have included 18 studies with 1087 participants of whom 545 received HS compared to 542 who received IS. All participants were over 18 years of age and all trials excluded high-risk patients (ASA IV). All trials assessed haematological parameters peri-operatively and up to three days post-operatively.There were three (< 1%) deaths reported in the IS group and four (< 1%) in the HS group, as assessed at 90 days in one study. There were no reports of serious adverse events. Most participants were in a positive fluid balance postoperatively (4.4 L IS and 2.5 L HS), with the excess significantly less in HS participants (MD -1.92 L, 95% confidence interval (CI) -2.61 to -1.22 L; P < 0.00001). IS participants received a mean volume of 2.4 L and HS participants received 1.49 L, significantly less fluid than IS-treated participants (MD -0.91 L, 95% CI -1.24 to -0.59 L; P < 0.00001). The maximum average serum sodium ranged between 138.5 and 159 in HS groups compared to between 136 and 143 meq/L in the IS groups. The maximum serum sodium was significantly higher in HS participants (MD 7.73, 95% CI 5.84 to 9.62; P < 0.00001), although the level remained within normal limits (136 to 146 meq/L).A high degree of heterogeneity appeared to be related to considerable differences in the dose of HS between studies. The quality of the evidence for the outcomes reported ranged from high to very low. The risk of bias for many of the studies could not be determined for performance and detection bias, criteria that we assess as likely to impact the study outcomes.

Authors' conclusions: HS reduces the volume of intravenous fluid required to maintain people undergoing surgery but transiently increases serum sodium. It is not known if HS affects survival and morbidity, but this should be examined in randomized controlled trials that are designed and powered to test these outcomes.

PubMed Disclaimer

Conflict of interest statement

Shrum, Bradly: none identified McArthur, Eric: none identified Burns, Karen: none identified Chruch, Brian: none identified Znadja, Tammy: none identified McAlister, Vivian: none identified

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study.
4
4
Funnel plot of comparison: 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 1.4 Total volume of crystalloid administered (L).
5
5
Funnel plot of comparison: 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 3.10 Peak serum sodium (meq/L) by dose of HS.
1.1
1.1. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Mortality during the study period.
1.2
1.2. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Serious adverse events during the study period.
1.3
1.3. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) measured at the end of the recovery period.
1.4
1.4. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L).
1.5
1.5. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Diuresis during study period (L).
1.6
1.6. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Peak serum sodium (meq/L).
1.7
1.7. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Final serum sodium (meq/L).
1.8
1.8. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Maximum intraoperative serum osmolarity (mOsm/kg H2O).
1.9
1.9. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Maximum intraoperative pulmonary artery wedge pressure (mm Hg).
1.10
1.10. Analysis
Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Maximum intraoperative cardiac index (L/min/M2).
2.1
2.1. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) measured during the study period: studies at low risk of bias.
2.2
2.2. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Total volume of crystalloid administered (L): studies at low risk of bias.
2.3
2.3. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Diuresis during study period (L): studies at low risk of bias.
2.4
2.4. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Peak serum sodium (meq/L): studies at low risk of bias.
2.5
2.5. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Final serum sodium (meq/L): studies at low risk of bias.
2.6
2.6. Analysis
Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Maximum intraoperative serum osmolarity (mOsm/kg H2O): studies at low risk of bias.
3.1
3.1. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) by type of surgery.
3.2
3.2. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Fluid balance (L) by dose of HS.
3.3
3.3. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) by volume given to control group.
3.4
3.4. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L) by type of surgery.
3.5
3.5. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Total volume of crystalloid administered (L) by dose of HS.
3.6
3.6. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Diuresis during study period (L) by type of surgery.
3.7
3.7. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Diuresis during study period (L) by dose of HS.
3.8
3.8. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Diuresis during study period (L) by volume given to control group.
3.9
3.9. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Peak serum sodium (meq/L) by type of surgery.
3.10
3.10. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Peak serum sodium (meq/L) by dose of HS.
3.11
3.11. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 11 Peak serum sodium (meq/L) by volume given to control group.
3.12
3.12. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 12 Final serum sodium (meq/L) by type of surgery.
3.13
3.13. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 13 Final serum sodium (meq/L) by dose of HS.
3.14
3.14. Analysis
Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 14 Final serum sodium (meq/L) by volume given to control group.

Update of

References

References to studies included in this review

Baraka 1994 {published data only}
    1. Baraka A, Taha S, Ghabach M, Sibaii A, Nader A, Matta M. Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia 1994;72(2):227‐8. [MEDLINE: ] - PubMed
Bruegger 2005 {published data only}
    1. Bruegger D, Bauer A, Rehm M, Niklas M, Jacob M, Irlbeck M, et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine 2005;33(3):556‐63. [MEDLINE: ] - PubMed
Cross 1989 {published data only}
    1. Cross JS, Gruber DP, Burchard KW, Singh AK, Moran JM, Gann DS. Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma 1989;29(6):817‐25. [MEDLINE: ] - PubMed
    1. Cross JS, Gruber DP, Gann DS, Singh AK, Moran JM, Burchard KW. Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery 1989;209(6):684‐91. [MEDLINE: ] - PMC - PubMed
Durasnel 1999 {published data only}
    1. Durasnel P, Cresci L, Madougou M, Idrissa A, Cheriff I, Falandry L, et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation 1999;18(6):631‐5. [MEDLINE: ] - PubMed
Ishikawa 1996 {published data only}
    1. Ishikawa G. The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui 1996;45(2):205‐14. [MEDLINE: ] - PubMed
Jarvela 2000 {published data only}
    1. Jarvala K. Email correspondence (January 4, 2007) 2007.
    1. Jarvela K, Honkonen SE, Jarvela T, Koobi T, Kaukinen S. The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia 2000;91:1461‐5. - PubMed
    1. Jarvela K, Koobi T, Kauppinen P, Kaukinen S. Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica 2001;45(6):776‐81. [MEDLINE: ] - PubMed
Jarvela 2001 {published data only}
    1. Jarvala K. Email correspondence (January 4, 2007) 2007.
    1. Jarvela K, Kaukinen S. Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology 2001;18(2):100‐7. [MEDLINE: ] - PubMed
    1. Jarvela K, Kaukinen S. Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 2002;16(1):43‐6. [MEDLINE: ] - PubMed
    1. Jarvela K, Koskinen M, Kaukinen S, Koobi T. Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2001;15(2):210‐5. [MEDLINE: ] - PubMed
Kato 1996 {published data only}
    1. Kato S, Goto F. Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia 1996;10:170‐5. - PubMed
Kimura 1994 {published data only}
    1. Kimura K, Takaori M. The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology 1994;43(8):1141‐7. - PubMed
Kølsen‐Petersen 2004 {published data only}
    1. Kølsen‐Petersen JA, Nielsen JO, Bendtzen K, Tonnesen E. Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica 2004;48(2):224‐33. [MEDLINE: ] - PubMed
    1. Kølsen‐Petersen JA, Nielsen JO, Tonnesen EM. Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology 2004;100(5):1108‐18. [MEDLINE: ] - PubMed
    1. Kølsen‐Petersen JA, Rasmussen TB, Krog J, Hokland M, Tonnesen EK. Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma 2006;61(5):1100‐6. [MEDLINE: ] - PubMed
Lavu 2014 {published and unpublished data}
    1. Lavu H, Sell NM, Carter TI, Winter JM, Maguire DP, Gratch DM, et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery 2014;290(3):445‐55. - PubMed
    1. Lavu, H. Personal communication. Personal communication January 2015.
Leverve 2008 {published data only}
    1. Leverve X, Boon C, Hakim T, Anwar M, Siregar E, Mustafa I. Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine 2008;34:1796‐1803. - PubMed
Shackford 1983 {published data only}
    1. Shackford SR, Sise MJ, Fridlund PH, Rowley WR, Peters RM, Virgilio RW, et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery 1983;94(1):41‐51. - PubMed
Shackford 1987 {published data only}
    1. Shackford SR, Fortlage DA, Peters RM, Hollingsworth‐Fridlund P, Sise MJ. Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics 1987;164(2):127‐36. [MEDLINE: ] - PubMed
Shao 2013 {published data only (unpublished sought but not used)}
    1. Shao L, Wang B, Wang S, Mu F, Gu K. Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo) 2013;68(3):323‐8. - PMC - PubMed
Veroli 1992 {published data only}
    1. Veroli P, Benhamou D. Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia 1992;69(5):461‐4. - PubMed
Wang 1997 {published data only}
    1. Wang BW, Chiou YH, Chen WB, Peng TY, Leung HK. Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica 1997;35(2):85‐90. [MEDLINE: ] - PubMed
Younes 1988 {published data only}
    1. Younes RN, Bechara MJ, Langer B, Aun F, Birolini D, Kuznieck S, et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira 1988;34(5):150‐4. [MEDLINE: ] - PubMed

References to studies excluded from this review

Auler 1987 {published data only}
    1. Auler JOC, Pereira MHC, Gomide‐Amaral RV, Stolf NG, Jatene AD, Rocha e Silva M. Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms. Surgery 1987;101:594‐601. - PubMed
Auler 1992 {published data only}
    1. Auler JOC Jr, Zin WA, Martins MA, Younes RN, Negri EM, Hoelz C, et al. Respiratory system mechanics in patients treated with isotonic or hypertonic NaCl solutions. Circulatory Shock 1992;36(4):243‐8. - PubMed
Li 2014 {published data only}
    1. Li J, Wang B, Wang S, Mu F. Effects of hypertonic saline ‐ hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures. International Journal of Clinical and Experimental Medicine 2014;7(8):2266‐72. - PMC - PubMed
Li 2015 {published data only}
    1. Li Q, Chen H, Hao JJ, Yin NN, Xu M, Zhou JX. Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double‐blinded, randomised controlled trial. BMC Anesthesiology 2015;15:138. - PMC - PubMed
    1. NCT02037815. Correlation of measured and calculated serum osmolality during mannitol or hypertonic saline infusion in patients after craniotomy: a study protocol and statistical analysis plan for a randomised controlled trial. clinicaltrials.gov/ct2/show/NCT02037815. - PMC - PubMed
Shao 2005 {published data only}
    1. Shao YS, Zhang YT, Peng KQ, Quan ZY. Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma. World Journal of Gastroenterology 2005;11(11):1577‐81. [MEDLINE: ] - PMC - PubMed
Yang Z 2014 {published data only}
    1. Yang Z, Zong Z, Ke C, Wei Y, Yu D, Wang L, et al. Hetastarch with hypertonic saline loading is a better choice for the maintenance of systemic and pulmonary circulation during general and epidural anesthesia. Panminerva Medicine 2014;56(1):35‐40. - PubMed
Yousefshahi F 2013 {published data only}
    1. Yousefshahi F, Bashirzadeh M, Abdollahi M, Mojtahedzadeh M, Salehiomran A, Jalali A, et al. Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft. Journal of the Tehran Heart Centre 2013;8(1):21‐7. - PMC - PubMed

Additional references

Arkiliç 2003
    1. Arkiliç CF, Taguchi A, Sharma N, Ratnaraj J, Sessler DI, Read TE, et al. Supplemental perioperative fluid administration increases tissue oxygen pressure. Surgery 2003;133(1):49‐55. [MEDLINE: ] - PubMed
Brandstrup 2003
    1. Brandstrup B, Tonnesen H, Beier‐Holgersen R, Hjortso E, Ording H, Lindorff‐Larsen K, et al: Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor‐blinded multicenter trial. Annals of Surgery 2003;238(5):641‐8. [MEDLINE: ] - PMC - PubMed
Bunn 2004
    1. Bunn F, Roberts I, Tasker R, Akpa E. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD002045.pub2; MEDLINE: ] - DOI - PMC - PubMed
Clopper 1934
    1. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26(4):404‐13.
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629‐34. [PUBMED: 9310563] - PMC - PubMed
GRADE 2004
    1. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.) 2004;328(7454):1490‐8. [MEDLINE: ] - PMC - PubMed
Grocott 2005
    1. Grocott MP, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesthesia and Analgesia 2005;100(4):1093‐106. [MEDLINE: ] - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kumar 2006
    1. Kumar S, Fowler M, Gonzalez‐Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurological Research 2006;28(3):360‐6. [MEDLINE: ] - PubMed
Lobo 2002
    1. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet 2002;359(9320):1812‐8. [MEDLINE: ] - PubMed
Lundh 2012
    1. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] - DOI - PubMed
Ogden 2005
    1. Ogden AT, Mayer SA, Connolly ES Jr. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005;57(2):207‐15. [MEDLINE: ] - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rizoli 2006
    1. Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, Tien H, et al. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double‐blinded trial. Annals of Surgery 2006;243(1):47‐57. [MEDLINE: ] - PMC - PubMed
Sterne 2001a
    1. Sterne JAC, Egger M, Smith GD. Investigating and dealing with publication and other biases in meta‐analysis. BMJ 2001;323(7304):101‐5. - PMC - PubMed
Sterne 2001b
    1. Sterne JAC, Egger M. Funnel plots for detecting bias in meta‐analysis: Guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046‐55. - PubMed
Wade 1997
    1. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran‐70 in treating trauma: a meta‐analysis of controlled clinical studies. Surgery 1997;122(3):609‐16. [MEDLINE: ] - PubMed
Wood 2008
    1. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.) 2008;336(7644):601‐5. - PMC - PubMed

References to other published versions of this review

McAlister 2006
    1. McAlister V, Burns KEA, Znajda T, Church B. Hypertonic saline for peri‐operative fluid management. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD006233] - DOI - PubMed
McAlister 2010
    1. McAlister V, Burns KEA, Znajda T, Church B. Hypertonic saline for peri‐operative fluid management. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD005576] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources